TFG Asset Management GP Ltd - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TFG Asset Management GP Ltd ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2019$1,098,000
+10.8%
1,000,0000.0%0.16%
-7.9%
Q3 2019$991,000
-65.8%
1,000,000
-64.3%
0.18%
-57.9%
Q2 2019$2,895,000
+2.3%
2,800,0000.0%0.42%
+19.3%
Q1 2019$2,830,000
-62.1%
2,800,000
-63.6%
0.35%
-70.1%
Q4 2018$7,469,000
-13.1%
7,700,0000.0%1.18%
+14.6%
Q3 2018$8,592,000
+9.1%
7,700,0000.0%1.03%
-4.5%
Q2 2018$7,875,000
+5.5%
7,700,0000.0%1.08%
-6.8%
Q1 2018$7,466,000
+23.7%
7,700,0000.0%1.16%
+26.2%
Q4 2017$6,036,000
-26.2%
7,700,000
-24.5%
0.92%
-31.0%
Q3 2017$8,180,000
+26.8%
10,200,0000.0%1.33%
+38.2%
Q2 2017$6,453,000
-1.6%
10,200,0000.0%0.96%
-22.0%
Q1 2017$6,557,000
-35.6%
10,200,000
+5.2%
1.23%
-39.2%
Q4 2016$10,181,000
+3.5%
9,700,000
+34.7%
2.02%
+8.6%
Q3 2016$9,839,0007,200,0001.86%
Other shareholders
INOTEK PHARMACEUTICALS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 9,700,000$10,181,0002.02%
Telemetry Investments, L.L.C. 1,000,000$1,040,0000.59%
DAFNA Capital Management LLC 600,000$618,0000.54%
Bruce & Co., Inc. 2,000,000$2,080,0000.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 5,700,000$5,928,0000.29%
Orbimed Advisors 7,000,000$7,354,0000.09%
Baker Brothers Advisors 5,000,000$5,167,0000.05%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 2,000,000$2,044,000,0000.04%
Citadel Advisors 15,000,000$15,394,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 1,000,000$1,033,0000.01%
View complete list of INOTEK PHARMACEUTICALS CORP shareholders